Results 111 to 120 of about 137,198 (351)
ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors.
Eric L. Simpson +12 more
wiley +1 more source
Erwiderung auf Herrn Dr. G. Behrend's Aufsatz: „Ueber Nervenläsion und Haarausfall mit Bezug auf die Alopecia areata” [PDF]
Max Joseph
openalex +1 more source
Introduction: Alopecia areata is a type of non-scarring alopecia, which is thought to be associated with T-cell mediated immune response. Objective: This study aims to compare the levels of serum inflammatory markers before and after treatment in ...
Icim Komurcugil, Nermin Karaosmanoğlu
doaj +1 more source
FUNDAMENTOS: A alopecia androgenética é a causa mais comum de perda progressiva de cabelo. Geralmente ocorre em doentes com predisposição hereditária para esse tipo de alopecia e com androgénios circulantes.
Inês Lobo +2 more
doaj +1 more source
Establishing the financial burden of alopecia areata and its predictors
Background Alopecia areata (AA) can have a significant impact on wellbeing. Consequently, individuals with AA often seek treatments or products to promote hair regrowth or camouflage their hair loss that incur a financial cost to the individual ...
Fabio Zucchelli +3 more
doaj +1 more source
Klinische und experimentelle Beobachtung über Alopecia (Hypotrichosis) congenita [PDF]
A. Büschke
openalex +1 more source
In adults with atopic dermatitis and chronic pruritus, the mental comorbidity of Somatic Symptom Disorder is associated with higher average and worst pruritus intensity, higher psychological distress and lower quality of life. Additionally, there were nonsignificant changes in cutaneous nerve fiber densities in skin biopsies.
Stefan M. Kahnert +13 more
wiley +1 more source
Therapeutic Considerations Related to Finasteride Administration in Male Androgenic Alopecia and Benign Prostatic Hyperplasia [PDF]
Finasteride has been used extensively until now as a relative efficient therapeutic option for male androgenic alopecia and benign prostatic hyperplasia.
Baconi, Daniela L +10 more
core +1 more source
ABSTRACT Background There is a growing body of literature suggesting that GLP‐1 receptor agonists (GLP‐1RAs) may be associated with hair loss; however, primary literature is sparse. Additionally, it is not well‐established which types of hair loss may be associated with GLP‐1RA use. Objectives This study aims to assess associations between GLP‐1RAs and
Lauren M. Ching +2 more
wiley +1 more source

